CT Scan and PET Scan Market Size, Share Global Analysis Report, 2026-2034

Industry Insights

[235+ Pages Report] According to Facts & Factors, the global CT Scan and PET Scan market size was estimated at USD 10.5 billion in 2025 and is expected to reach USD 18.5 billion by the end of 2034. The CT Scan and PET Scan industry is anticipated to grow by a CAGR of 6.5% between 2026 and 2034. The CT Scan and PET Scan Market is driven by the rising prevalence of chronic diseases like cancer and cardiovascular conditions, coupled with technological advancements in hybrid imaging systems and increasing demand for precise early diagnosis.

Market Overview

The CT Scan and PET Scan market encompasses advanced medical imaging technologies designed to provide detailed anatomical and functional insights into the human body. CT scans utilize X-ray technology to generate high-resolution cross-sectional images of internal structures, while PET scans employ radioactive tracers to reveal metabolic and physiological processes. These modalities, frequently integrated into hybrid PET-CT systems, play a critical role in disease diagnosis, staging, treatment planning, and monitoring across oncology, cardiology, neurology, and other therapeutic areas.

The market supports healthcare providers in delivering non-invasive, accurate diagnostics that improve patient outcomes and reduce the need for exploratory surgeries.

Key Insights

• As per the analysis shared by our research analyst, the global CT Scan and PET Scan market size is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2026-2034).
• In terms of revenue, the global CT Scan and PET Scan market size was valued at around USD 10.5 billion in 2025 and is projected to reach USD 18.5 billion by 2034.
• The market is driven by the rising prevalence of cancer and cardiovascular diseases, rapid adoption of hybrid imaging technologies, and growing investments in healthcare infrastructure worldwide.
• Based on the type segment, the hybrid PET-CT scanners subsegment dominated the market with approximately 58% share because it delivers simultaneous anatomical and functional data in a single procedure, enhancing diagnostic precision and workflow efficiency.
• Based on the application segment, the oncology subsegment dominated the market with approximately 55% share as it enables accurate tumor detection, staging, metastasis assessment, and therapy response evaluation critical for cancer management.
• Based on the end-user segment, the hospitals subsegment dominated the market with approximately 62% share owing to high patient throughput, availability of specialized radiology departments, and integration with comprehensive care pathways.
• Based on the region segment, the North America region dominated the market with approximately 38% share due to advanced healthcare infrastructure, favorable reimbursement policies, and early adoption of cutting-edge imaging technologies.

Growth Drivers

• Rising Prevalence of Chronic Diseases

The global increase in cancer, cardiovascular disorders, and neurological conditions has significantly boosted demand for advanced imaging solutions that enable early detection and precise monitoring. CT and PET scans provide clinicians with actionable insights that support personalized treatment plans and improve survival rates.

This trend is further amplified by aging populations and lifestyle factors, compelling healthcare systems to expand diagnostic capabilities and integrate these technologies into routine screening protocols.

• Technological Advancements in Hybrid Systems

Innovations such as digital detectors, AI-powered image reconstruction, and total-body PET-CT designs have reduced scan times, lowered radiation doses, and improved image quality. These developments make hybrid systems more accessible and effective for complex cases.

Ongoing R&D investments by leading manufacturers continue to drive product differentiation, encouraging hospitals and diagnostic centers to upgrade their equipment fleets.

Restraints

• High Cost of Equipment and Procedures

The substantial capital investment required for CT and PET scanners, along with ongoing maintenance and radiotracer expenses, limits adoption in cost-sensitive regions and smaller facilities. Reimbursement challenges in certain markets further constrain growth.

These financial barriers often delay technology upgrades and restrict access in developing healthcare systems despite clinical need.

• Radiation Exposure Concerns

Patient and staff safety issues related to ionizing radiation from CT and PET procedures prompt stricter regulatory oversight and demand for dose-reduction technologies. This has slowed uptake in sensitive populations such as pediatrics.

Clinicians and regulators continue to balance diagnostic benefits against long-term radiation risks, influencing purchasing decisions.

Opportunities

• Expansion in Emerging Markets

Rapid healthcare infrastructure development in Asia-Pacific and Latin America, supported by government initiatives and private investments, creates substantial growth potential for affordable and portable imaging solutions.

Rising medical tourism and increasing awareness of advanced diagnostics are expected to accelerate market penetration in these regions.

• Integration of AI and Personalized Medicine

AI algorithms for automated image analysis, predictive diagnostics, and theranostics applications are opening new avenues for precision medicine. Hybrid systems combined with radiopharmaceutical innovations enhance treatment monitoring capabilities.

These advancements position CT and PET technologies at the forefront of next-generation healthcare delivery.

Challenges

• Shortage of Skilled Professionals

Limited availability of trained radiologists, nuclear medicine specialists, and technicians hinders efficient utilization of complex imaging systems worldwide.

Training programs and retention strategies remain critical to overcoming this operational bottleneck.

• Stringent Regulatory and Reimbursement Hurdles

Complex approval processes for new radiotracers and devices, coupled with varying reimbursement policies across countries, delay market entry and adoption.

Manufacturers must navigate diverse regulatory landscapes while ensuring cost-effectiveness to sustain growth.

Report Scope

Market Segmentation

The CT Scan and PET Scan market is segmented by type, application, end-user, and region.

Based on Type Segment, the CT Scan and PET Scan market is divided into CT Scanners, PET Scanners, Hybrid PET-CT Scanners, and others. The hybrid PET-CT scanners segment is the most dominant because it combines structural and metabolic imaging in one session, reducing patient discomfort, minimizing scan time, and delivering superior diagnostic accuracy that drives clinical decision-making and market expansion. The CT Scanners segment is the second most dominant as standalone high-slice systems remain essential for routine anatomical imaging in emergency care, trauma assessment, and broad clinical applications, supporting widespread accessibility and cost-effective diagnostics across healthcare settings.

Based on Application Segment, the CT Scan and PET Scan market is divided into Oncology, Cardiology, Neurology, and others. The oncology segment is the most dominant due to its indispensable role in tumor detection, staging, recurrence monitoring, and treatment response evaluation, where functional PET data complements CT anatomy to guide targeted therapies and improve patient survival outcomes. The cardiology segment is the second most dominant as PET-CT enables precise assessment of myocardial perfusion, viability, and inflammation, aiding in the management of coronary artery disease and heart failure while driving demand for non-invasive cardiovascular diagnostics.

Based on End-User Segment, the CT Scan and PET Scan market is divided into Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and others. The hospitals segment is the most dominant owing to high patient volumes, integrated multidisciplinary teams, and the ability to offer comprehensive imaging services alongside treatment, which accelerates procedure throughput and revenue generation. The diagnostic imaging centers segment is the second most dominant because specialized standalone facilities provide cost-efficient, high-volume outpatient services with flexible scheduling and advanced equipment utilization that appeal to referring physicians and insured patients seeking quick access.

Recent Developments

• In 2025, GE Healthcare deepened its collaboration with Stanford Medicine to pioneer total-body PET-CT technology focused on ultra-fast, low-dose imaging and multi-organ assessment, significantly enhancing diagnostic speed and patient comfort.
• Positron Corporation secured agreements in early 2025 to supply multiple NeuSight PET/CT scanners to leading cardiovascular practices, expanding access to advanced cardiac imaging solutions.
• S.L. Raheja Hospital in India launched an AI-enabled digital PET-CT unit in June 2025, delivering superior image quality and supporting precision oncology diagnostics.
• Auburn Community Hospital unveiled a new PET/CT scanner in August 2025 with federal funding support, strengthening regional diagnostic capabilities in the United States.
• Philips introduced the CT 5300 scanner with AI-enabled Precise software in late 2024, which continued to gain traction through 2025 for streamlined workflows and dose optimization across global installations.

Regional Analysis

• North America to dominate the global market

North America leads the CT Scan and PET Scan market primarily through the United States, where world-class research institutions, extensive hospital networks, and strong reimbursement frameworks facilitate rapid adoption of cutting-edge hybrid systems. The region benefits from high healthcare spending, robust regulatory support for innovative radiopharmaceuticals, and close collaboration between manufacturers and clinical centers that accelerate technology integration into standard care protocols. Canada complements this dominance with universal healthcare coverage that prioritizes advanced diagnostics for oncology and cardiology patients.

Europe maintains a strong position driven by countries such as Germany, the United Kingdom, and France, which possess sophisticated public healthcare systems and emphasize early disease detection programs. Germany stands out with its engineering expertise and dense network of university hospitals that pioneer AI-enhanced imaging research, while the UK focuses on national screening initiatives that increase demand for PET-CT in cancer care. France and other Western European nations invest heavily in upgrading aging equipment fleets to meet rising chronic disease burdens.

Asia Pacific is experiencing accelerated growth fueled by China and India, where expanding middle-class populations and government healthcare modernization programs are rapidly increasing access to advanced imaging. China leads with massive investments in hospital infrastructure and domestic manufacturing capabilities that reduce costs and improve availability of hybrid scanners across tier-1 and tier-2 cities. India is emerging as a key hub through medical tourism, rising private diagnostic chains, and initiatives to address cancer prevalence in rural areas via mobile and affordable imaging solutions.

Latin America shows steady progress led by Brazil and Mexico, where improving economic conditions and public-private partnerships are enhancing diagnostic infrastructure in major urban centers. These countries are focusing on oncology and cardiology applications to tackle growing non-communicable disease burdens while gradually adopting hybrid technologies through international collaborations.

The Middle East & Africa region is gradually expanding, with the United Arab Emirates and South Africa serving as gateways through modern medical cities and international hospital investments. These nations prioritize high-end imaging for medical tourism and specialized care, while broader African markets begin to incorporate basic CT systems supported by international aid programs targeting cancer and infectious disease management.

Competitive Analysis

The global CT Scan and PET Scan market is dominated by players:

• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems Corporation
• Hitachi Ltd.
• Neusoft Medical Systems Co., Ltd.
• Positron Corporation
• Cubresa Inc.
• Mediso Medical Imaging Systems

The global CT Scan and PET Scan market is segmented as follows:

By Type

• CT Scanners
• PET Scanners
• Hybrid PET-CT Scanners
• Others

By Application

• Oncology
• Cardiology
• Neurology
• Others

By End-User

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America